Hepatocyte growth factor and soluble cMet levels in plasma are prognostic biomarkers of mortality in patients with severe acute kidney injury

• Main Authors: Lilin Li (Author), Jung Nam An (Author), Jeonghwan Lee (Author), Dong Jin Shin (Author), Shi Mao Zhu (Author), Jin Hyuk Kim (Author), Dong Ki Kim (Author), Dong-Ryeol Ryu (Author), Sejoong Kim (Author), Jung Pyo Lee (Author)
• Format: Book
• Published: The Korean Society of Nephrology, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background Hepatocyte growth factor (HGF)/cMet pathway is necessary for repair and regeneration following acute kidney injury (AKI). We evaluated the clinical potential of plasma HGF and soluble cMet as prognostic biomarkers for severe AKI requiring continuous renal replacement therapy (CRRT). Metho...